Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents

被引:31
|
作者
Smith, A
Jackson, MS
Kennedy, H
机构
[1] Glasgow Dent Hosp & Sch, Infect Res Grp, Glasgow G2 3JZ, Lanark, Scotland
[2] Royal Hosp Sick Children, Yorkhill NHS Trust, Dept Microbiol, Glasgow G3 8SJ, Lanark, Scotland
关键词
D O I
10.1080/00365540410019435
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 155 viridans group streptococci blood culture isolates identified by the Rapid ID32 Strep system were tested for their minimum inhibitory concentrations (MICs) to penicillin, amoxicillin, ceftriaxone, erythromycin, clindamycin, rifampicin, vancomycin and teicoplanin using the E-test. The following species were identified: S. oralis (n = 67), S. mitis (n = 66), S. sanguis (n = 7), S. salivarius (n = 5), S. parasanguis (n = 4), S. gordonii (n = 3) and S. mutans (n = 3). S. oralis and S. mitis demonstrated the highest levels of resistance to the agents tested. There were 27% of S. oralis isolates resistant to penicillin, 51% resistant to erythromycin and 6% resistant to clindamycin. For S. mitis 11% were resistant to penicillin, 40% resistant to erythromycin and 3% resistant to clindamycin. Penicillin resistant isolates (MIC greater than or equal to 2 mg/l) also demonstrated decreased susceptibility to other antimicrobial agents tested in this study. High level resistance (MIC greater than or equal to 2 mg/l) to ceftriaxone was found in 12 isolates. The isolates identified as ceftriaxone resistant comprised S. oralis (n = 7), S. mitis (n = 4) and S. parasanguis (n = 1). This study has highlighted the difference in susceptibility between different species of viridans group streptococci. These findings are of concern in the light of spread of antibiotic resistance genes from S. oralis and S. mitis to the more invasive pneumococcus.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 50 条
  • [21] Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea
    Uh, Y
    Shin, DH
    Jang, IH
    Hwang, GY
    Lee, MK
    Yoon, KJ
    Kim, HY
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) : 1095 - 1097
  • [22] Antimicrobial Resistance of Community-acquired Bloodstream Isolates of Viridans Group Streptococci
    R. L. Yap
    L. A. Mermel
    J. Maglio
    Infection, 2006, 34 : 339 - 341
  • [23] A genetic study of group A streptococcal susceptibility to cath antimicrobial peptides
    Lauth, X
    Ohtake, T
    Zaiou, M
    Nizet, V
    Gallo, RL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 314 - 314
  • [24] Antimicrobial resistance of community-acquired bloodstream isolates of viridans group streptococci
    Yap, R. L.
    Mermel, L. A.
    Maglio, J.
    INFECTION, 2006, 34 (06) : 339 - 341
  • [25] Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe
    Hedberg, M
    Nord, CE
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) : 475 - 488
  • [26] Induction of In Vitro Resistance to Penicillin in Viridans Group Streptococci and Its Effect on Susceptibility Pattern of Other Antimicrobial Agents
    Dhotre, Shree V.
    Nagoba, Basavraj S.
    Suryawanshi, Namdev M.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2016, 5 (02) : 101 - 106
  • [27] Pattern of Polymicrobial Isolates and Antimicrobial Susceptibility from Blood
    Shabbir, Samina
    Jamil, Sana
    Hafiz, Saleem
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (07): : 585 - 588
  • [28] Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci
    Chun, Sejong
    Huh, Hee Jae
    Lee, Nam Yong
    ANNALS OF LABORATORY MEDICINE, 2015, 35 (02) : 205 - 211
  • [29] SUSCEPTIBILITY OF URINE ISOLATES OF STAPHYLOCOCCUS-SAPROPHYTICUS TO ANTIMICROBIAL AGENTS
    SCHNEIDER, PF
    RILEY, TV
    PATHOLOGY, 1991, 23 (02) : 135 - 138
  • [30] INVITRO SUSCEPTIBILITY OF 400 CLINICAL ISOLATES TO SELECTED ANTIMICROBIAL AGENTS
    ROY, I
    ELDER, HA
    COUPERUS, JJ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (05): : 846 - 852